January 27, 2026
1 min read

Siegfried extends M&A streak, gaining 3 sites from SK Capital and advancing US onshoring aims

Siegfried has signed agreements to acquire the controlled drug substance businesses of the Noramco Group and Extractas Bioscience. With the deals, Siegfried gains API sites in Wilmington, Delaware; Athens, Georgia; and Australia.

Leave a Reply

Your email address will not be published.

Previous Story

9 influencers shaping health information online, for better or worse

Next Story

US consumers turn to unaccredited nutrition advice from social media influencers and AI

Previous Story

9 influencers shaping health information online, for better or worse

Next Story

US consumers turn to unaccredited nutrition advice from social media influencers and AI

Latest from Blog

Go toTop